Skip to content

Shareholdings of the Board of Directors and the Executive Management Board

The tables below show the shareholdings of Orion Corporation's Board of Directors and members of the Executive Management Board in the Company on 31 December 2023. The Company’s executive management held 0.67% of all of the Company’s shares and 1.65% of the total votes on 31 December 2023. These shareholdings include holdings by controlled corporations.
Managers' transactions

Shareholdings of the Board of Directors on 31 December 2023

Director A shares  B shares  Total 
Veli-Matti Mattila, Chair starting from 20 March 2024 0 7 311 7 311
Mikael Silvennoinen, Chair and member until 20 March 2024 0 9 737 9 737
Hilpi Rautelin, Vice Chair 4 800 4 734 9 534
Kari Jussi Aho 85 263 1 835 87 098
Maziar Mike Doustdar 0 955 955
Ari Lehtoranta 0 4 428 4 428
Karen Lykke Sørensen 535 500 40 085 575 585
Board total 0 955 955
  625 563 70 040 695 603

Shareholdings of the Executive Management Board on 31 December 2023

Member Position A shares  B shares on  Total 
Liisa Hurme President & CEO 0 30 020 30 020
Satu Ahomäki SVP, Generics and Consumer Health 0 42 049 42 049
Olli Huotari SVP, Corporate Functions 0 76 431 76 431
Juhani Kankaanpää SVP, Global Operations 0 5 012 5 012
Jari Karlson CFO until 30 April 2024 0 44 771 44 771
Virve Laitinen SVP, Corporate Strategy and Program Management, Management Board Member until 31 March 2024 0 22 773 22 773
Niclas Lindstedt SVP, Animal Health 0 6 302 6 302
Hao Pan SVP, Branded Products 0 13 138 13 138
Outi Vaarala SVP, Innovative Medicines / Research & Development 0 7 098 7 098
Management total   0 247 594 247 594